Cadena Bio Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Cadena Bio General Information

Description

Developer of evolutionary ingredients designed to feed and nourish the human microbiome. The company's evolutionary ingredients include Essential Glycans, derived from nature, to nourish specific beneficial bacteria for optimized diversification of the microbiome as well as selectively targets bacterial strains that confer specific health benefits and offer unmatched functionality for easy adoption into a wide array of product formulations, enabling physicians to provide nutrients to the patients body.

Contact Information

Website
www.cadenabio.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 47 Moulton Street
  • Cambridge, MA 02138
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 47 Moulton Street
  • Cambridge, MA 02138
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cadena Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jul-2017 Completed Out of Business
2. Early Stage VC (Series B) 30-Jun-2016 Completed Startup
1. Early Stage VC (Series A) 14-Apr-2016 $1.5M $1.5M Completed Startup
To view Cadena Bio’s complete valuation and funding history, request access »

Cadena Bio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A-1
Series A 19,595,871 $0.000100 8% $0.07 $0.07 1x $0.07 29.39%
To view Cadena Bio’s complete cap table history, request access »

Cadena Bio Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Cadena Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3250048-A1 Oligosaccharide compositions for use animal feed and methods of producing thereof Active 26-Jan-2015
EP-3250048-A4 Oligosaccharide compositions for use animal feed and methods of producing thereof Active 26-Jan-2015
EP-3250048-B1 Oligosaccharide compositions for use animal feed and methods of producing thereof Active 26-Jan-2015
ES-2755042-T3 Oligosaccharide compositions for use as animal feed and methods of producing them Active 26-Jan-2015
US-10849337-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof Active 26-Jan-2015 A23K20/163
To view Cadena Bio’s complete patent history, request access »

Ready to get started?

Request a free trial

Cadena Bio FAQs

  • When was Cadena Bio founded?

    Cadena Bio was founded in 2016.

  • Where is Cadena Bio headquartered?

    Cadena Bio is headquartered in Cambridge, MA.

  • What industry is Cadena Bio in?

    Cadena Bio’s primary industry is Biotechnology.

  • Is Cadena Bio a private or public company?

    Cadena Bio is a Private company.

  • What is Cadena Bio’s current revenue?

    The current revenue for Cadena Bio is .

  • How much funding has Cadena Bio raised over time?

    Cadena Bio has raised $5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »